Marijuana can get a person high, unleash creative prowess, and, in the case of overindulgence, might also make him or her act dumb. But thereâs more to pot than running around acting stoned, like actor Seth Rogen might have everyone believe in the 2008 classic stoner comedy, Pineapple Express.
For starters, with cannabis legal in Canada, thereâs no need to visit a sketchy âweed dealerâ anymore. Second, when used medically, the drug has some benefits.
In fact, almost 62 percent of consumers of CBDâCBD, short for cannabidiol, is a compound found in the cannabis plantâreported using it to treat a medical condition. The data was highlighted in a 2018 study conducted on over 2,000 individuals, recruited through social media, from Oct. 25, 2017 to Jan. 25, 2018.
Here are the most common health conditions CBD is used for:
From treating joint pain and muscle spasm to gout and malaria, cannabis has been in use since 2,900 BC. Now with legalization gradually gaining momentum across the globe, CBDâs pain-relieving properties are once again in the spotlight, so much so that itâs being touted as a âmiracle drug.â
âThe most common use for medical marijuana in the United States is for pain control,â Peter Grinspoon, MD, was quoted saying in Harvard Health Publishing. âWhile marijuana isnât strong enough for severe pain (for example, post-surgical pain or a broken bone), it is quite effective for the chronic pain that plagues millions of Americans, especially as they age.â
CBD, for its medical properties, is often the star student. But when combined with its rouge sibling THC (short for tetrahydrocannabinol, a cannabis compound responsible for causing the high), the two can reportedly pack an even greater punch.
Cannabis-based oral spray, Sativex, for example, is a mixture of THC and CBD and is used to treat pain related to multiple sclerosis (MS) and rheumatoid arthritis.
The product is widely acknowledged for both its benefitsâand side effects. Since its launch in 2011, the product is now âregistered across 29 countries worldwide,â including Canada.
âThe question of whether marijuanaâproduced from the flowering top of the hemp plant, cannabis sativaâshould be used for symptom management in MS is a complex one,â cautions the National Multiple Sclerosis Society in an article on its website. âIt is generally agreed that better therapies are needed for distressing symptoms of MSâincluding pain, tremor and spasticity (stiffness and muscle spasms)âthat may not be sufficiently relieved by available treatments. Still, there are uncertainties about the benefits of marijuana relative to its side effects.â
The total number of people living with depression in the world is more than 322 million, as per a report by the World Health Organization; pain and depression co-exist in almost 80 percent of them.
For many, cannabis is a go-to option: mental health conditions, including anxiety disorders, mood disorders (like depression) and post-traumatic stress disorder (PTSD), are the tops reasons U.S. patients use cannabis, per a 2019 report by CB2 Insights.
Way back, too, cannabis was used and advertised as an anti-depressant. English clergyman Robert Burton once recommended âusing âhemp-seedâ for curing depression in his book, The Anatomy of Melancholy, first published in 1621,â The GrowthOp reports. Moreover, data from a 2006 study evaluating 4,400 adult Internet users, also found there was decreased depression in marijuana users.
The trick is in figuring which cannabis strain to pick.
From a panic attack to generalized anxiety disorder (GAD), anxiety can manifest in numerous ways and is characterized by an inner state of unease. âAs anxiety disorders go, GAD is one of the most commonâstudies indicate it may affect about three of the Canadian population any given year,â TheGrowthOp reports.Â
A 2018 Canadian study by Whistler Therapeutics was able to identify strains that helped reduce symptoms, and others that had the opposite effect. THC âand trans-nerolidol (an essential oil found in the cannabis plant) have significant correlations with increased anxiolytic (preventing anxiety) activity. Other cannabis compounds such as Guiaol, eucalyptol, γ-terpinene, α-phellandrene, 3-carene and sabinene hydrate all have significant correlations with decreased anxiolytic activity. Further studies are needed to better understand the cannabis varieties,â the study adds.
Caffeine canât always be blamed if a good nightâs rest is far, far away. Nearly 50 percent of the adult population in the United States experience sleeping problems. That number is no joke; neither is the data that suggests cannabis can help reduce that number.
The 2018 study highlights how sleep aids, including antidepressants, benzodiazepines and anti-psychotics, have enormous negative side effects.
âAlthough no U.S. state has legalized medical cannabis for the treatment of sleep disorders, results show that the consumption of cannabis flower is associated with significant improvements in perceived insomnia,â the report adds.
Once again, CBD takes the spotlight when it comes to treatments for epilepsy; the most commonly used strain, in this case, is Charlotteâs Web.
The strain, which has high-CBD and low-THC, is named after Charlotte Figi, a Colorado resident who suffered from a rare form of epilepsy called the Dravetâs Syndrome and experienced repeated seizures. But it is extremely important to note that âcannabis has only been shown in children with rare genetic seizure disorders. These children have either Dravetâs Syndrome or Lennox-Gastaut Syndrome,â The GrowthOp reports.
For a lot of cancer patients, traditional medicine just doesnât help when it comes to treating nausea and vomiting induced by chemotherapy (CINV). Cannabis, in this case, has offered a welcome Plan B for some.
When administered orally, two cannabis-based medicines, nabilone and dronabinol, have helped improve CINV symptoms. âHowever, cannabis should never be used during pregnancy as they pose known and unknown harms to both a woman and her developing fetus,â Angela Smith, PhD, founder and principal of Toronto-based Catalyst Life Science Consulting, was quoted saying in The GrowthOp article.
Itâs no surprise that 80 percent of NFL players use cannabis. A lifetime of playing football could possibly lead to players developing the dreaded C.T.E. that can be diagnosed only through an autopsy.
C.T.E., short for chronic traumatic encephalopathy, is a neurodegenerative disease that results in brain and part of the nervous system to worsen over time.
Repetitive brain trauma like blows to the head causes C.T.E.âmostly because the trauma leads to the build-up of a protein called tau, one thatâs been suspected to play a role in the development of Alzheimerâs.
Accounting for cannabisâ pain management properties, cannabis can potentially be an option for players. While the research, in this case, is nascent, an Israeli study on rats and mice found how endocannabinoids reduced brain damage. Another study on rats, published in the Annals of the New York Academy of Sciences, found that âcannabis had neuroprotective (protecting and preventing nerve injuries and degeneration) qualities as an antioxidant.â
Â
Want to keep up to date on whatâs happening in the world of cannabis?  Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.